Nippon India Pharma Fund - Growth

+

Invest

Explore On

Equity
Sector - Healthcare
Rating N.A.
Plan

517.39 +2.37 (0.46%) NAV as on 13 Nov, 2025

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)8113.59
CAGR 4.00%
Exit Load1.00%
Expense ratio1.82%
CategoryEquity
Min Investment5000
Min SIP100
Launch Date2004-06-05

Asset Allocation

Holdings As On - 15 November 2025

Holdings

Sectors

Name
Value (Cr)
Holding %

Lupin
589.45
7.26%

Divi's Laboratories
568.97
7.01%

Cipla
525.42
6.48%

Gland Pharma
263.01
3.24%

Peer Comparison

Fund Name
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth8.55%
SBI Healthcare Opportunities Fund Regular Growth5.26%
Nippon India Pharma Fund - Growth4%
DSP Healthcare Fund Regular Growth-1.9%
Mirae Asset Healthcare Fund Regular Growth4.55%

Risk & Volitility

Alpha 5.93%
Beta 0.89
Sharpe Ratio0.90
Std Deviation 15.24%
Tracking Error 5.26%

About Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

The Nippon India Pharma Fund - Growth has an AUM of 8113.59 crores & has delivered CAGR of 17.67% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.82%. The minimum investment in Nippon India Pharma Fund - Growth is Rs 5000 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Lupin, Divi's Laboratories & Cipla.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Retail (Drugs).

Some of the similar funds are ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth, SBI Healthcare Opportunities Fund Regular Growth, Nippon India Pharma Fund - Growth, DSP Healthcare Fund Regular Growth, Mirae Asset Healthcare Fund Regular Growth. Nippon India Pharma Fund - Growth has a sharpe ratio of 0.90 & a standard deviation of 15.24%.